FDA Approves Ketamine Nasal Spray as First and Only Standalone Therapy for Treatment-Resistant Depression
Veriheal
JUNE 12, 2025
Clinicians typically use ketamine as a general anesthetic, but they also use it to alleviate treatment-resistant chronic pain and seizures. Two forms of ketamine therapy for mental health conditions have been studied: intravenous (IV) infusions and a brand-name nasal spray containing esketamine called Spravato.
Let's personalize your content